vanda pharmaceuticals inc
Howard H. Pien
Chairman, Member of Nominating/Corporate Governance Committee and Member of Compensation Committee, Vanda Pharmaceuticals, Inc.
|Age||Total Calculated Compensation||This person is connected to 34 board members in 5 different organizations across 8 different industries.|
See Board Relationships
Mr. Howard H. Pien is an Advisor to Warburg Pincus. Mr. Pien served as the Chief Executive Officer and President of Medarex Inc. from June 14, 2007 to September 2009 and its Chairman of the Board from May 15, 2008 to September 2009. He joined Medarex, Inc. in June 2007. He has over 25 years of pharmaceutical and biotechnology industry experience. Mr. Pien served as the Chief Executive Officer and President of Chiron Corp. since April 2003. From April 2006 to June 2007, ...
2200 Pennsylvania Avenue NWPhone: 202-734-3400
Washington, District Of Columbia 20037
Board Members Memberships*
Lead Independent Director and Chairman of Nominating & Corporate Governance Committee
Former Chairman, Chief Executive Officer and Member of Stock Option Plan Administration Committee
Former Chairman of the Board, Chief Executive Officer and President
Chairman, Member of Nominating/Corporate Governance Committee and Member of Compensation Committee
Director and Chairman of Compensation Committee
Director, Member of Audit Committee and Member of Compensation Committee
Director, Member of Compensation Committee and Member of Nominating & Corporate Governance Committee
Carnegie Mellon University
Massachusetts Institute of Technology
Annual Compensation*There is no Annual Compensation data available.
|Brenton L. Saunders J.D.||Chief Executive Officer, President, Director, Chairman of Compensation Committee and Member of Compliance Committee|
Forest Laboratories Inc.
|John C. Lechleiter Ph.D.||Chairman, Chief Executive Officer and President|
Eli Lilly and Company
|Pascal Soriot||Chief Executive Officer, Executive Director and Member of Disclosure Committee|
|Ulf Arne Wiinberg||Chief Executive Officer, President and Member of the Board of Management|
H. Lundbeck A/S
|Masayo Tada||Chief Executive Officer, President, Representative Director and Chairman of Risk Management Committee|
Dainippon Sumitomo Pharma Co., Ltd.
|--||Compensation as of Fiscal Year --.|
Post a JobJobs
- Detroit, MI | Wayne State UniversityPosted: Nov 26
- New York, NY | AGORAPosted: Nov 25
- Irving, TX | ADT Security ServicesPosted: Dec 03
- Bentonville, AR | WalmartPosted: Dec 03